Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer - PubMed

Affiliations

• PMID: 11940583
• DOI: 10.1074/jbc.M200729200

Free article

Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer

Mohammed A Ayoub et al. J Biol Chem. 2002.

Free article

Abstract

Several G protein-coupled receptors have been shown to exist as homo-and hetero-oligomeric complexes in living cells. However, the link between ligand-induced receptor activation and its oligomerization state as well as the proportion of the total receptor population that can engage in oligomeric complexes remain open questions. Here, the closely related human MT1 and MT2 melatonin receptors (MT1R, MT2R) were used to address these issues. Bioluminescence resonance energy transfer (BRET) experiments in living HEK 293 cells revealed that these receptors form homo- and hetero-oligomers. Constitutive energy transfer was observed for all receptor combinations at physiological expression levels and could be detected in single cell BRET experiments. Inhibition of the energy transfer by dilution of the BRET partners identified MT1R and MT2R dimers as the predominant receptor species, and this oligomerization state did not change upon agonist and antagonist binding. Agonists, neutral antagonists, and inverse agonists all promoted increases in BRET values for MT2R but not for MT1R homodimers in living cells and isolated plasma membranes. This indicates that no correlation could be inferred between the receptor activation state and the dimerization state of the receptor. This also suggests that ligand-promoted BRET increases represent specific ligand-induced conformational changes of pre-existing dimers rather then increased dimerization. The observation that ligands favored the energy transfer within the hetero-oligomer from MT1R to MT2R but not in the reverse orientation, from MT2R to MT1R, supports this view.

Similar articles

• Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).

  Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, Bouvier M. Angers S, et al. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3684-9. doi: 10.1073/pnas.97.7.3684. Proc Natl Acad Sci U S A. 2000. PMID: 10725388 Free PMC article.

• Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.

  Angers S, Salahpour A, Bouvier M. Angers S, et al. Annu Rev Pharmacol Toxicol. 2002;42:409-35. doi: 10.1146/annurev.pharmtox.42.091701.082314. Annu Rev Pharmacol Toxicol. 2002. PMID: 11807178 Review.

• Homo- and hetero-dimeric complex formations of the human oxytocin receptor.

  Devost D, Zingg HH. Devost D, et al. J Neuroendocrinol. 2004 Apr;16(4):372-7. doi: 10.1111/j.0953-8194.2004.01188.x. J Neuroendocrinol. 2004. PMID: 15089977 Review.

Cited by

• Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.

  Bonnefond A, Clément N, Fawcett K, Yengo L, Vaillant E, Guillaume JL, Dechaume A, Payne F, Roussel R, Czernichow S, Hercberg S, Hadjadj S, Balkau B, Marre M, Lantieri O, Langenberg C, Bouatia-Naji N; Meta-Analysis of Glucose and Insulin-Related Traits Consortium (MAGIC); Charpentier G, Vaxillaire M, Rocheleau G, Wareham NJ, Sladek R, McCarthy MI, Dina C, Barroso I, Jockers R, Froguel P. Bonnefond A, et al. Nat Genet. 2012 Jan 29;44(3):297-301. doi: 10.1038/ng.1053. Nat Genet. 2012. PMID: 22286214 Free PMC article.

• Role of antibodies in developing drugs that target G-protein-coupled receptor dimers.

  Hipser C, Bushlin I, Gupta A, Gomes I, Devi LA. Hipser C, et al. Mt Sinai J Med. 2010 Jul-Aug;77(4):374-80. doi: 10.1002/msj.20199. Mt Sinai J Med. 2010. PMID: 20687183 Free PMC article. Review.

• The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts.

  Savi P, Zachayus JL, Delesque-Touchard N, Labouret C, Hervé C, Uzabiaga MF, Pereillo JM, Culouscou JM, Bono F, Ferrara P, Herbert JM. Savi P, et al. Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):11069-74. doi: 10.1073/pnas.0510446103. Epub 2006 Jul 11. Proc Natl Acad Sci U S A. 2006. PMID: 16835302 Free PMC article.

• Antibodies against G-protein coupled receptors: novel uses in screening and drug development.

  Gupta A, Heimann AS, Gomes I, Devi LA. Gupta A, et al. Comb Chem High Throughput Screen. 2008 Jul;11(6):463-7. doi: 10.2174/138620708784911465. Comb Chem High Throughput Screen. 2008. PMID: 18673273 Free PMC article. Review.

• Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease.

  Tosini G, Owino S, Guillaume JL, Jockers R. Tosini G, et al. Bioessays. 2014 Aug;36(8):778-87. doi: 10.1002/bies.201400017. Epub 2014 Jun 5. Bioessays. 2014. PMID: 24903552 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • Guide to Pharmacology

• Miscellaneous

  • NCI CPTAC Assay Portal